More recently, Kalenderoglou et al. showed that CBD targets the mammalian target of rapamycin (mTOR) pathway in leukemia cells, decreasing the phosphorylation of AKT, mTOR and ribosomal S6, affecting leukemia cell size [27]. This evidence concerns the gene AKT1 and leukemia.